Drug Farm Doses First Patient in Phase 1 Trial for ALPK1 Inhibitor, DF-003

First-in-human trial for DF-003, the 2nd compound from IDInVivo and MedChem5 platform to enter clinical…

BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab)

Regulatory marketing applications for U.S. and EU under review, with plans to expand TEVIMBRA commercial…

Add a Touch of Kyoto Style to Your Home with the Second Wave of SOU・SOU X Doraemon Collectibles

Introducing the SOU GOOD UV Umbrella with Quick-Dry Pouch, Limited Edition SOU・SOU Doraemon Plushie and…

starsleep Enters Hong Kong Market with Health Tech Products To Help the Silver Generation Get Better Sleep

HONG KONG SAR - Media OutReach - 19 September 2023 - starsleep, the technology-driven healthcare…

Comba Telecom Awarded Multi-Year BSA Frame Agreement with UAE’s leading Operator du for Network Expansion and Evolution

HONG KONG SAR - Media OutReach - 19 September 2023 - Comba Telecom Systems Holdings…

Rocket Lab Launch Update

MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), today…

QuantaSing Expands Global Presence with Acquisition of Kelly’s Education

HONG KONG SAR - Media OutReach - 19 September 2023 - QuantaSing Group Limited (NASDAQ:…

Ant Group Introduces 10 Asian E-Wallets to Chinese Mainland in Major Expansion of Alipay+ Cross-Border Mobile Payment Ecosystem

A global first, the “Alipay+-in-China” (A+China) Program makes it possible for users of 10 leading…

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

LONDON & PLEASANTON, Calif.--(BUSINESS WIRE)--Otsuka Pharmaceutical Europe Ltd. (Otsuka) and Astex Pharmaceuticals, Inc. (Astex) today…